NHC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
408.0M
+6.9%
381.8M
-1.2%
386.5M
+1.0%
382.7M
+2.1%
374.9M
Cost of Revenue
0
0
0
0
0
Gross Profit
408.0M
+6.9%
381.8M
-1.2%
386.5M
+1.0%
382.7M
+2.1%
374.9M
Operating Expenses
359.1M
+2.7%
349.6M
-1.1%
353.4M
+0.3%
352.3M
+3.4%
340.8M
R&D
0
0
0
0
0
SG&A
241.9M
+2.9%
235.1M
+0.8%
233.2M
+0.0%
233.2M
+2.9%
226.5M
Operating Income
48.9M
+51.7%
32.3M
-2.6%
33.1M
+9.0%
30.4M
-10.9%
34.1M
EBITDA
60.1M
+37.0%
43.9M
-2.3%
44.9M
+8.1%
41.5M
-7.9%
45.1M
Net Income
40.5M
+12.3%
36.1M
+43.3%
25.2M
-38.6%
41.0M
+70.1%
24.1M
EPS (Basic)
$2.58
+11.7%
$2.31
+44.4%
$1.60
-36.8%
$2.53
+65.4%
$1.53
EPS (Diluted)
$2.54
+11.9%
$2.27
+43.7%
$1.58
-36.8%
$2.50
+64.5%
$1.52
Shares (Diluted)
15.9M
+0.6%
15.8M
+0.2%
15.7M
+0.5%
15.7M
+0.4%
15.6M
National Healthcare (NHC) โ€” Financials